Prevalence of NAFLD in T1DM Patients
Recruiting · NCT06445361 · Interventional (participants receive a specific treatment) · Lead sponsor: Ziekenhuis Oost-Limburg
View the official record on ClinicalTrials.gov →Interventions studied
FibroScan
What this trial is about
To determine the prevalence of NAFLD in T1DM patients.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- T1DM
- ≥ 18 years of age
- Written informed consent obtained
Exclusion criteria
- Excessive alcohol use
- Exclusion of other causes of liver disease and secondary causes of liver steatosis
Where it is running
1 location listed.
- Ziekenhuis Oost-Limburg - Genk, Limburg, Belgium